Teva Pharmaceuticals Usa, Inc.
Federal Contractor · Rank #1907
Teva Pharmaceuticals Usa, Inc. Federal Spending Profile
Teva Pharmaceuticals Usa, Inc. is a smaller federal recipient, with $38.5M in total federal obligations across 25 awards in the USAspending.gov record. That places Teva Pharmaceuticals Usa, Inc. #1907 among federal contractors ranked by total obligations.
Every one of Teva Pharmaceuticals Usa, Inc.'s 25 federal awards is a procurement contract rather than a grant — the company sells goods or services to the government rather than receiving grant funding.
Teva Pharmaceuticals Usa, Inc.'s federal work runs through a single agency relationship: Department of Defense. With no other agency customers in the record, the company's federal revenue rises or falls with that one relationship.
The federal government's spending with Teva Pharmaceuticals Usa, Inc. falls almost entirely under Other Services ($24.4M), which describes the kind of goods or services the company is paid to deliver.
Its largest single recent award is a $929K contract from the Department of Defense, described in the federal record as "Adenovirus Vaccine Efficiency Study.."
Track Teva Pharmaceuticals Usa, Inc.
Subscribe for TaxDollarData updates by email. No spam, unsubscribe anytime.
Spending by Agency
Recent Awards
| Description | Agency | Start Date | Amount |
|---|---|---|---|
| 8510325537!ADENOVIRUS TYPE 4 A | Department of Defense | Dec 14, 2023 | $2.4M |
| 8510559015!ADENOVIRUS TYPE 4 A | Department of Defense | Apr 9, 2024 | $1.6M |
| 8510325475!ADENOVIRUS TYPE 4 A | Department of Defense | Dec 14, 2023 | $1.5M |
| 8510766857!ADENOVIRUS TYPE 4 A | Department of Defense | Jul 19, 2024 | $1.4M |
| 8510688482!ADENOVIRUS TYPE 4 A | Department of Defense | Jun 13, 2024 | $1.4M |
| 8510634433!ADENOVIRUS TYPE 4 A | Department of Defense | May 15, 2024 | $1.4M |
| 8510902080!ADENOVIRUS TYPE 4 A | Department of Defense | Sep 18, 2024 | $1.3M |
| 8510401601!ADENOVIRUS TYPE 4 A | Department of Defense | Jan 25, 2024 | $1.3M |
| 8510839749!ADENOVIRUS TYPE 4 A | Department of Defense | Aug 22, 2024 | $1.1M |
| 8510500489!ADENOVIRUS TYPE 4 A | Department of Defense | Mar 13, 2024 | $1.1M |
| 8510462163!ADENOVIRUS TYPE 4 A | Department of Defense | Feb 22, 2024 | $953K |
| ADENOVIRUS VACCINE EFFICIENCY STUDY. | Department of Defense | Aug 5, 2020 | $929K |
| 8510325476!ADENOVIRUS TYPE 4 A | Department of Defense | Dec 14, 2023 | $916K |
| 8510840306!ADENOVIRUS TYPE 4 A | Department of Defense | Aug 22, 2024 | $635K |
| 8510839844!ADENOVIRUS TYPE 4 A | Department of Defense | Aug 22, 2024 | $635K |
| 8510767083!ADENOVIRUS TYPE 4 A | Department of Defense | Jul 19, 2024 | $635K |
| 8510634439!ADENOVIRUS TYPE 4 A | Department of Defense | May 15, 2024 | $635K |
| 8510634438!ADENOVIRUS TYPE 4 A | Department of Defense | May 15, 2024 | $635K |
| 8510500531!ADENOVIRUS TYPE 4 A | Department of Defense | Mar 13, 2024 | $635K |
| 8510462257!ADENOVIRUS TYPE 4 A | Department of Defense | Feb 22, 2024 | $635K |
All federal spending data sourced from USAspending.gov, the official source for federal award data as mandated by the Government Accountability Office.
Teva Pharmaceuticals Usa, Inc. Federal Contracts FAQ
Teva Pharmaceuticals Usa, Inc. has received $38,516,256 in total federal obligations across 25 awards and 25 contracts.
Teva Pharmaceuticals Usa, Inc. works with 1 federal agencies, including Department of Defense. The largest agency relationships are based on total dollar obligations.
Teva Pharmaceuticals Usa, Inc. has received federal awards in multiple states.
Teva Pharmaceuticals Usa, Inc. is ranked #1907 among the largest federal contractors by total obligation amount. Rankings are based on USASpending.gov data for FY2024.
Explore Other Federal Contractors
Spending figures represent total federal obligations for FY2024, as reported through USASpending.gov. Rankings are based on aggregate obligation amounts across all contract, grant, and direct payment awards.